KI-Beratung Beta

Produktbild: Therapeutics of Mycobacterium

Therapeutics of Mycobacterium

147,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

This book covers all the latest aspects related to the therapeutics of Mycobacterium . It includes therapy for the treatment of PTB, EPTB, and MDR/XDR-TB. Moreover, it also includes the treatment of NTM, challenges, and guidelines. Chapters cover the chemotherapy/drugs from traditional to most advanced...

Beschreibung

This book covers all the latest aspects related to the therapeutics of
Mycobacterium
. It includes therapy for the treatment of PTB, EPTB, and MDR/XDR-TB. Moreover, it also includes the treatment of NTM, challenges, and guidelines. Chapters cover the chemotherapy/drugs from traditional to most advanced drugs used for the treatment of all forms of tuberculosis and NTM. This book also includes newer therapy, immunomodulators, nanotechnology approach, immunotherapy, combinatorial therapy, Ayurvedic medicine, and repurposing of drugs. Also, discuss the challenges and opportunities for the treatment of disease. This book offers assistance to postgraduate medical students, researchers, medical practitioners, postdoctoral fellows, microbiologist, nurses, as well as public health officers working in tuberculosis control programs in understanding various modalities for the treatment of tuberculosis and drug-resistance tuberculosis.

Portrait


Dr. Amit Singh
, doctorate from Division of Clinical Microbiology and Molecular Medicine, All India Institute of Medical Sciences, New Delhi. He is an assistant professor of Medical Microbiology and working in the field of infectious disease for the last 15 years. He has more than 70 peer-reviewed publications, 1 book, 15 book chapters, and 2 patents, and delivers various oral and poster presentations at national and international conferences. He was awarded with many national and international awards. He is an editorial member and reviewer of various national and international journals.


Dr. Divakar Sharma
, doctorate from National JALMA Institute for leprosy and other Mycobacterial disease Agra (ICMR and Jiwaji University, Gwalior), India. He has more than 16 years of experience in the field of tuberculosis research and drug resistance. He has published more than 80 articles and book chapters in international journals and books. He also edited a book for Bentham Science Publishers and Springer Nature. He also serves as an associate editor in various international journals (BMC, frontiers, Bentham Science). He is also having various national awards and fellowships.


Dr. Srikanth Prasad Tripathy
has a doctorate in Internal Medicine from the Madras Medical College in Chennai, India. He has worked with the Indian Council of Medical Research for 34 years and subsequently has been working as Director of Medical Research with the Dr D Y Patil Medical College, Hospital and Research Centre in Pune, India, for the last four years. His research focused on HIV, tuberculosis, and COVID, and he has more than 180 publications in national and international journals and has contributed to chapters in 12 books.

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

20.05.2026

Abbildungen

XXVII, 331 p. 42 illus., 40 illus. in color.

Herausgeber Amit Singh + weitere

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

20.05.2026

Abbildungen

XXVII, 331 p. 42 illus., 40 illus. in color.

Herausgeber
Verlag Springer Singapore
Seitenzahl

331

Maße (L/B/H)

24,1/16/2,4 cm

Gewicht

719 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-981-9202-55-3

Herstelleradresse

Springer-Verlag GmbH
Europaplatz 3
69115 Heidelberg
DE

Email: ProductSafety@springernature.com

Ein neues Kapitel für Ihre Bücher

Ein neues Kapitel für Ihre Bücher

Schenken Sie Ihren alten Schätzen ein zweites Leben und erhalten Sie dafür eine Thalia Geschenkkarte.

Jetzt verkaufen
Jetzt verkaufen

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Therapeutics of Mycobacterium

  • .- Chapter 1: Combating Mycobacterial Infections An Overview of Therapeutic Strategies 



    .- Chapter 2: Combating Pulmonary Tuberculosis Challenges, Advances, and the Quest for New Therapies



    .- Chapter 3: Anti-tuberculosis chemotherapy for extra-pulmonary tuberculosis (EPTB) 



    .- Chapter 4: Treatment, challenges and opportunity of latent TB infection



    .- Chapter 5: Treatment and clinical management of MDR/XDR TB



    .- Chapter 6: Harnessing the Power of Nature Herbal Medicine in the Fight Against Tuberculosis



    .- Chapter 7: Bacteriophages: A Potential Therapy against Mycobacterium tuberculosis



    .- Chapter 8: Nanotechnology-based drug repurposing for the treatment of Tuberculosis



    .- Chapter 9: Drug Repositioning: An Alternative Strategy to Tackle Multi-Drug-Resistant M. tuberculosis



    .- Chapter 10:Treatment of NTM, challenges, guidelines, chemotherapy



    .- Chapter 11:Treatment and Management of Zoonotic Tuberculosis: Challenges and Opportunities



    .- Chapter 12:Treatment and challenges of tubercular meningitis



    .- Chapter 13:Surgical management of pleural tuberculosis      



    .- Chapter 14:Navigating Treatment Challenges Tuberculosis in Patients with Psychiatric Illnesses    



    .- Chapter 15:Immunomodulators as therapy for mycobacteria.